-
Product Insights
NewAllergic Rhinitis – Drugs In Development, 2024
Empower your strategies with our Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy or runny nose, sneezing, swollen...
-
Product Insights
NewAlpha-1 Antitrypsin Deficiency (A1AD) – Drugs In Development, 2024
Empower your strategies with our Alpha-1 Antitrypsin Deficiency (A1AD) – Drugs In Development, 2024 report and make more profitable business decisions. Alpha-antitrypsin deficiency is an inherited disease that occurs due to lack of alpha-1 antitrypsin (AAT), a protein that protects the lungs. Symptoms include shortness of breath and wheezing, lung infections, rapid heartbeat, weight loss and vision problems. Predisposing factors include smoking, exposure to dust, chemical fumes, and infections. The Alpha-1 Antitrypsin Deficiency (A1AD) drugs in development market research report provide...
-
Product Insights
NewKidney Fibrosis – Drugs In Development, 2024
Empower your strategies with our Kidney Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. Predisposing factors are trauma, injury, infections, surgery, environmental factors, and exposure to chemicals or radiation. Symptoms include pain, problems related to urination, nausea, and vomiting. The condition may be managed with...
-
Product Insights
NewAnemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024
Empower your strategies with our Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024 report and make more profitable business decisions. Renal anemia is a disease in which the patient has an unusually low count of red blood cells associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, shortness...
-
Product Insights
NewNon Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2024
Empower your strategies with our Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – Drugs In Development, 2024 report and make more profitable business decisions. Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. Most people with NAFLD experience no signs and symptoms and no complications, but in some people with the disease, the fat that accumulates can cause inflammation and scarring in the liver. The most common symptoms that bring NAFLD to medical attention are...
-
Product Insights
NewInterstitial Lung Fibrosis – Drugs In Development, 2024
Empower your strategies with our Interstitial Lung Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Interstitial Lung Fibrosis or interstitial lung disease (ILD) is a group of diseases that cause scarring of the lungs (fibrosis) or lung parenchyma. If untreated it can lead to respiratory failure and death. Symptoms start with inflammation and can result in bronchiolitis, vasculitis, and alveolitis. Exposure to hazardous chemicals or materials like asbestos, hypersensitivity, drug-induced, underlying autoimmune conditions, family history, smoking,...
-
Product Insights
NewEnterocolitis – Drugs In Development, 2024
Empower your strategies with our Enterocolitis – Drugs In Development, 2024 report and make more profitable business decisions. Enterocolitis is an inflammation of the large and small intestines. Symptoms include fever, abdominal swelling, nausea, diarrhea, rectal bleeding, and sluggishness. Causes of enterocolitis include inflammation of the intestinal tissues, delayed gastric emptying, abdominal wall erythema, apnea, sepsis, and cardiovascular collapse. Treatment includes antibiotics. The Enterocolitis drugs in development market research report provide comprehensive information on the therapeutics under development for Enterocolitis, complete...
-
Product Insights
NewNecrotizing Enterocolitis – Drugs In Development, 2024
Empower your strategies with our Necrotizing Enterocolitis – Drugs In Development, 2024 report and make more profitable business decisions. Necrotizing Enterocolitis is the most common type of infection seen in neonates where inflammation of the intestine leads to mucosal damage causing necrosis or death of cells and tissues. Most observed in premature neonates or in infants weighing less than 1500g leading the mortality rate to greater than 50 percent. Genetic mutations also play a role in this condition. Bacterial invasion into...
-
Company Profile
Liminal BioSciences Inc – Company Profile
Liminal BioSciences Inc (Liminal), formerly ProMetic Life Sciences Inc, is a biopharmaceutical company that focuses on plasma-derived therapeutics and small-molecule drug development. The company develops products for the treatment of fibrosis, including respiratory, liver, and kidney diseases. Liminal develops drug candidates based on two drug discovery platforms: small molecule therapeutics (PSMT), and plasma-derived therapeutics. The Company intends to capitalize on its drug discovery platform and knowledge base to build an early-stage drug portfolio. The company owns research and development facilities...
Add to Basket -
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...